Genesis New Ventures, LLCAmended

Biotechnology · MISSOULA, MT

BiotechnologySEC Form D

Genesis New Ventures, LLC filed a Form D with the U.S. Securities and Exchange Commission on April 30, 2026, reporting $4,227,939 raised toward a $6,500,000 offering.

Incorporated in Indiana and based in MISSOULA, MT, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Genesis New Ventures, LLC has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Donald RunningExecutive Officer · Director
  • Daniel F JustinDirector
  • James A Bruce, Jr.Executive Officer · Director

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
$10.0MRaised

Senti Biosciences Holdings, Inc.

BiotechnologySouth San Francisco, CA
Genesis New Ventures, LLC raised $4.2M — SEC Form D